<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03237858</url>
  </required_header>
  <id_info>
    <org_study_id>92125179</org_study_id>
    <nct_id>NCT03237858</nct_id>
  </id_info>
  <brief_title>Multiple Cardiac Sensors for the Management of Heart Failure</brief_title>
  <acronym>MANAGE-HF</acronym>
  <official_title>Multiple Cardiac Sensors for the Management of Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The MANAGE-HF study is a multi-center, global, prospective, open label, multi-phase trial
      intended to evaluate the clinical efficacy of the HeartLogic heart failure diagnostic
      feature.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Phase I of the MANAGE-HF trial is not randomized, and is intended to evaluate the clinical
      integration of HeartLogic for managing patients with heart failure. There are no endpoints.

      Phase II of the MANAGE-HF trial will assess the clinical effectiveness of remote monitoring
      of heart failure patients with implanted CRT-D or ICD cardiac devices that contain the
      diagnostic feature HeartLogic. This feature uses S1 and S3 heart sounds, night time heart
      rate, thoracic impedance, and respiration to alert clinicians when a patient's heart failure
      is worsening. The MANAGE-HF study will compare remote monitoring using HeartLogic alerts to
      drive heart failure care against patients with remote monitoring but without HeartLogic
      alerts.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2017</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Anticipated">October 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>Expected to take 4 years from first patient enrollment</time_frame>
    <description>Freedom from all-cause mortality and heart failure hospitalization comparing patients managed with HeartLogic alerts versus those not managed with alerts. An endpoint event for each subject will be determined by the first occurrence of a heart failure hospitalization or death. A total of 864 endpoint events are needed to detect a difference between the two groups (alpha=0.05; power=90%; hazard ratio of 0.8).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart failure hospitalization</measure>
    <time_frame>Expected to take 4 years from first patient enrollment</time_frame>
    <description>Freedom from all-cause mortality and heart failure hospitalization comparing patients managed with HeartLogic alerts versus those not managed with alerts. An endpoint event for each subject will be determined by the first occurrence of a heart failure hospitalization or death. A total of 864 endpoint events are needed to detect a difference between the two groups (alpha=0.05; power=90%; hazard ratio of 0.8).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2700</enrollment>
  <condition>Heart Failure, Congestive</condition>
  <arm_group>
    <arm_group_label>HeartLogic ON</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ICD and CRT-D devices with HeartLogic alerts turned ON</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HeartLogic OFF</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>ICD and CRT-D devices with HeartLogic alerts turned OFF</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HeartLogic ON</intervention_name>
    <description>Remote management of patients with CRT-D or ICD devices and the HeartLogic diagnostic feature turned OFF</description>
    <arm_group_label>HeartLogic ON</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HeartLogic OFF</intervention_name>
    <description>Remote management of patients with CRT-D or ICD devices and the HeartLogic diagnostic feature turned ON</description>
    <arm_group_label>HeartLogic OFF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is age 18 or above, or of legal age to give informed consent

          2. Implanted with an cardiac resynchronization therapy defibrillator (CRT-D) or
             implantable cardioverter-defibrillator (ICD) device that has HeartLogic

          3. Current symptomatic heart failure or New York Heart Association Class II or III at the
             time of enrollment

          4. Remotely monitored by LATITUDE 5.0 (or future versions)

          5. Willing and capable of participating in all study visits and complying with
             medication/treatment requirements associated with this clinical study at an approved
             clinical study center.

          6. Meet at least one of the three following conditions:

               -  At least one documented hospitalization with a primary diagnosis of worsening for
                  heart failure during the 12 months prior to enrollment; or

               -  Unscheduled outpatient visit with IV diuretic therapy for acute worsening of HF
                  during 90 days prior to enrollment; or

               -  N-terminal-pro brain natriuretic peptide (NT-proBNP) greater than 600 pg/mL or
                  brain natriuretic peptide (BNP) greater than 150 pg/mL at any time during 90 days
                  prior to enrollment

        Exclusion Criteria:

          1. The subject is unable to sign or refuses to sign the patient informed consent

          2. Symptomatic heart failure at rest or New York Heart Association Class IV at the time
             of enrollment

          3. The subject is implanted with unipolar right atrial or right ventricular leads

          4. Subject has received or is scheduled to receive a heart transplant or ventricular
             assist device within the next 6 months

          5. Subject is pregnant or planning to become pregnant during the study

          6. Subject is enrolled in any other concurrent study (without prior written approval from
             Boston Scientific, excluding registries)

          7. Glomerular filtration rate &lt;25 mL/min who are non-responsive to diuretic therapy or
             are on chronic renal dialysis

          8. Regularly scheduled intravenous heart failure therapy (for example inotropes or
             diuretics)

          9. A life expectancy of less than 12 months per clinician discretion

         10. APPLICABLE TO PHASE II ONLY: Subject enrolled in Phase I of MANAGE-HF

         11. APPLICABLE TO PHASE II ONLY: Subject has been managed with HeartLogic Alerts ON at
             anytime within the past 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrian Hernandez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephen B Ruble, PhD</last_name>
    <phone>651-582-4397</phone>
    <email>stephen.ruble@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lauren Kinney</last_name>
    <email>lauren.kinney@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Center Research, LLC</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Marsh</last_name>
      <phone>256-519-8290</phone>
      <email>jmarsh@theheartcenter.md</email>
    </contact>
    <investigator>
      <last_name>Jay Dinerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of Northeast Arkansas</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kayla Rubino</last_name>
      <phone>870-935-6729</phone>
      <email>krubino@stbheart.com</email>
    </contact>
    <investigator>
      <last_name>Devi Nair, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Ramos</last_name>
      <phone>323-442-7983</phone>
      <email>melissa.ramos@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Rahul Doshi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Consultants</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manginder Sohal</last_name>
      <phone>925-274-2078</phone>
      <email>msohal@stanfordhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Steven Kang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharp Memorial Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Small</last_name>
      <phone>858-244-6889</phone>
      <email>dsmall@sdcardiac.com</email>
    </contact>
    <investigator>
      <last_name>Peter Hoagland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Maguire</last_name>
      <phone>415-768-5148</phone>
      <email>cmaguire@medicine.ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Byron Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaitlin Ketchum</last_name>
      <phone>303-724-6473</phone>
      <email>kaitlin.ketchum@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Larry Allen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacy Williams</last_name>
      <phone>404-712-0502</phone>
      <email>stacy.williams@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Andrew Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Parkview Hospital, Inc.</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Heffernan</last_name>
      <phone>260-266-5614</phone>
      <email>jessica.heffernan@parkview.com</email>
    </contact>
    <investigator>
      <last_name>Mark O/Shaughn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community Health Network</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46250</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J Kogline</last_name>
      <phone>317-621-8621</phone>
      <email>jkogline@community.com</email>
    </contact>
    <investigator>
      <last_name>Chad Bonhomme, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Cardiovascular Specialists</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Chalamidas</last_name>
      <phone>318-795-4638</phone>
    </contact>
    <contact_backup>
      <last_name>kchalamidas@acsdoctors.com</last_name>
    </contact_backup>
    <investigator>
      <last_name>Sherman Wiggins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centra Care Heart and Vascular Center</name>
      <address>
        <city>Cold Spring</city>
        <state>Minnesota</state>
        <zip>56320</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Humbert</last_name>
      <phone>320-656-7020</phone>
      <email>humberj@centracare.com</email>
    </contact>
    <investigator>
      <last_name>Moustapha Atoui, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>United Heart and Vascular</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Boben</last_name>
      <phone>651-241-2913</phone>
      <email>lisa.boben@allina.com</email>
    </contact>
    <investigator>
      <last_name>Alan Bank, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catholic Medical Center</name>
      <address>
        <city>Manchester</city>
        <state>New Hampshire</state>
        <zip>03102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Cornelius, RN</last_name>
      <phone>603-669-0413</phone>
      <email>elizabeth.cornelius@cmc-nh.org</email>
    </contact>
    <investigator>
      <last_name>Robert Capodilupo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna Oviedo</last_name>
      <phone>718-920-8780</phone>
      <email>joviedo@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Jooyoung Shin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Strong Memorial Hospital of the University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Wing</last_name>
      <phone>585-273-4128</phone>
      <email>laura_wing@urmc.rochester.edu</email>
    </contact>
    <investigator>
      <last_name>Atkas Mehmet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Gerstl</last_name>
      <phone>919-681-8983</phone>
      <email>susan.gerstl@dm.duke.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan Piccini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rex Hospital</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Johnson</last_name>
      <phone>919-784-4031</phone>
      <email>tiffany.johnson@unchealth.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Sidharth Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lindner Center for Research and Education at Christ Hosp</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Marsh</last_name>
      <phone>256-519-8276</phone>
      <email>jmarsh@theheartcenter.md</email>
    </contact>
    <investigator>
      <last_name>Eugene Chung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bethesda North Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sue Dorroh</last_name>
      <phone>513-865-1148</phone>
      <email>sue_dorroh@trihealth.com</email>
    </contact>
    <investigator>
      <last_name>Hemal Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PeaceHealth Sacred Heart Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Oregon</state>
        <zip>97477</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny O'Leary</last_name>
      <phone>541-222-1927</phone>
      <email>poleary@peacehealth.org</email>
    </contact>
    <investigator>
      <last_name>Matt Trojan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dena Jefferson</last_name>
      <phone>717-531-5967</phone>
      <email>djefferson1@hmc.psu.edu</email>
    </contact>
    <investigator>
      <last_name>John Boehmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants of Philadelphia</name>
      <address>
        <city>Yardley</city>
        <state>Pennsylvania</state>
        <zip>19067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Budzinski</last_name>
      <email>SharonB@ccpdocs.com</email>
    </contact>
    <investigator>
      <last_name>Christopher Schulze, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Everidge</last_name>
      <phone>843-792-2944</phone>
      <email>adamsde@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Gold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stern Cardiovascular</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill Guy</last_name>
      <phone>901-271-1000</phone>
      <email>jill.guy@sterncardio.com</email>
    </contact>
    <investigator>
      <last_name>David Lan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southeast Texas Clinical Research Center</name>
      <address>
        <city>Beaumont</city>
        <state>Texas</state>
        <zip>77702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Ellis</last_name>
      <phone>409-839-4003</phone>
      <email>mellis@setxcardiology.com</email>
    </contact>
    <investigator>
      <last_name>Paris Bransford, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberley Judson</last_name>
      <phone>757-388-2812</phone>
      <email>kajudso2@sentara.com</email>
    </contact>
    <investigator>
      <last_name>John Herre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 20, 2017</study_first_submitted>
  <study_first_submitted_qc>July 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2017</study_first_posted>
  <last_update_submitted>March 12, 2020</last_update_submitted>
  <last_update_submitted_qc>March 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>diagnostics</keyword>
  <keyword>heart sounds</keyword>
  <keyword>CRT-D</keyword>
  <keyword>ICD</keyword>
  <keyword>remote monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

